Literature DB >> 23993095

Allosteric activation of functionally asymmetric RAF kinase dimers.

Jiancheng Hu1, Edward C Stites2, Haiyang Yu2, Elizabeth A Germino2, Hiruy S Meharena3, Philip J S Stork4, Alexandr P Kornev5, Susan S Taylor6, Andrey S Shaw7.   

Abstract

Although RAF kinases are critical for controlling cell growth, their mechanism of activation is incompletely understood. Recently, dimerization was shown to be important for activation. Here we show that the dimer is functionally asymmetric with one kinase functioning as an activator to stimulate activity of the partner, receiver kinase. The activator kinase did not require kinase activity but did require N-terminal phosphorylation that functioned allosterically to induce cis-autophosphorylation of the receiver kinase. Based on modeling of the hydrophobic spine assembly, we also engineered a constitutively active mutant that was independent of Ras, dimerization, and activation-loop phosphorylation. As N-terminal phosphorylation of BRAF is constitutive, BRAF initially functions to activate CRAF. N-terminal phosphorylation of CRAF was dependent on MEK, suggesting a feedback mechanism and explaining a key difference between BRAF and CRAF. Our work illuminates distinct steps in RAF activation that function to assemble the active conformation of the RAF kinase.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23993095      PMCID: PMC3844432          DOI: 10.1016/j.cell.2013.07.046

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  54 in total

1.  S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.

Authors:  A Chiloeches; C S Mason; R Marais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Active Ras induces heterodimerization of cRaf and BRaf.

Authors:  C K Weber; J R Slupsky; H A Kalmes; U R Rapp
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

3.  Potent and selective pyrazole-based inhibitors of B-Raf kinase.

Authors:  Joshua D Hansen; Jonas Grina; Brad Newhouse; Mike Welch; George Topalov; Nicole Littman; Michele Callejo; Susan Gloor; Matthew Martinson; Ellen Laird; Barbara J Brandhuber; Guy Vigers; Tony Morales; Rich Woessner; Nikole Randolph; Joseph Lyssikatos; Alan Olivero
Journal:  Bioorg Med Chem Lett       Date:  2008-07-05       Impact factor: 2.823

4.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.

Authors:  Mathew J Garnett; Sareena Rana; Hugh Paterson; David Barford; Richard Marais
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

5.  A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.

Authors:  Damian F Brennan; Arvin C Dar; Nicholas T Hertz; William C H Chao; Alma L Burlingame; Kevan M Shokat; David Barford
Journal:  Nature       Date:  2011-03-27       Impact factor: 49.962

6.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.

Authors:  A J King; H Sun; B Diaz; D Barnard; W Miao; S Bagrodia; M S Marshall
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

7.  Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.

Authors:  M LaFevre-Bernt; F Sicheri; A Pico; M Porter; J Kuriyan; W T Miller
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

8.  Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression.

Authors:  A M Cacace; N R Michaud; M Therrien; K Mathes; T Copeland; G M Rubin; D K Morrison
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.

Authors:  R Marais; Y Light; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

View more
  128 in total

1.  Knock-in(g) RAF for a loop.

Authors:  Andrea Varga; Manuela Baccarini
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

2.  Dynamic architecture of a protein kinase.

Authors:  Christopher L McClendon; Alexandr P Kornev; Michael K Gilson; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-15       Impact factor: 11.205

3.  A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.

Authors:  Sai Krishna Athuluri-Divakar; Rodrigo Vasquez-Del Carpio; Kaushik Dutta; Stacey J Baker; Stephen C Cosenza; Indranil Basu; Yogesh K Gupta; M V Ramana Reddy; Lynn Ueno; Jonathan R Hart; Peter K Vogt; David Mulholland; Chandan Guha; Aneel K Aggarwal; E Premkumar Reddy
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

Review 4.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

5.  Kinase regulation by hydrophobic spine assembly in cancer.

Authors:  Jiancheng Hu; Lalima G Ahuja; Hiruy S Meharena; Natarajan Kannan; Alexandr P Kornev; Susan S Taylor; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2014-10-27       Impact factor: 4.272

6.  A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.

Authors:  Yu Sun; John A Alberta; Catherine Pilarz; David Calligaris; Emily J Chadwick; Shakti H Ramkissoon; Lori A Ramkissoon; Veronica Matia Garcia; Emanuele Mazzola; Liliana Goumnerova; Michael Kane; Zhan Yao; Mark W Kieran; Keith L Ligon; William C Hahn; Levi A Garraway; Neal Rosen; Nathanael S Gray; Nathalie Y Agar; Sara J Buhrlage; Rosalind A Segal; Charles D Stiles
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

7.  Analyses of the oncogenic BRAFD594G variant reveal a kinase-independent function of BRAF in activating MAPK signaling.

Authors:  Nicholas J Cope; Borna Novak; Zhiwei Liu; Maria Cavallo; Amber Y Gunderwala; Matthew Connolly; Zhihong Wang
Journal:  J Biol Chem       Date:  2020-01-12       Impact factor: 5.157

Review 8.  Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

Authors:  Matthew Dankner; April A N Rose; Shivshankari Rajkumar; Peter M Siegel; Ian R Watson
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

9.  Chemically Linked Vemurafenib Inhibitors Promote an Inactive BRAFV600E Conformation.

Authors:  Michael Grasso; Michelle A Estrada; Christian Ventocilla; Minu Samanta; Jasna Maksimoska; Jessie Villanueva; Jeffrey D Winkler; Ronen Marmorstein
Journal:  ACS Chem Biol       Date:  2016-09-06       Impact factor: 5.100

10.  Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.

Authors:  Martin Köhler; Michael Röring; Björn Schorch; Katharina Heilmann; Natalie Stickel; Gina J Fiala; Lisa C Schmitt; Sandra Braun; Sophia Ehrenfeld; Franziska M Uhl; Thorsten Kaltenbacher; Florian Weinberg; Sebastian Herzog; Robert Zeiser; Wolfgang W Schamel; Hassan Jumaa; Tilman Brummer
Journal:  EMBO J       Date:  2015-12-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.